Question-Based Review Not Raising Questions For Generic Sponsors, FDA

Initial experiences with question-based reviews of the chemistry, manufacturing and controls section of ANDAs suggest the quality initiative will not adversely affect the generics review process for sponsors

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Archive

More from Pink Sheet